Combined program
Compounded semaglutide + tirzepatide program
2 recorded programs. No comparable monthly price is verified. See the record for advertised amounts and conditions.
A combined program contains semaglutide and tirzepatide. Its ingredients do not establish a single coformulated dosage unit. See each record for the recorded route and dosage form.
Individual ingredient classification does not establish approval of the combined preparation. Compounded preparations are not themselves FDA-approved products. FDA information on compounded GLP-1 drugs.
Entries
More columns to the right? Scroll across the table to see all details.
| Entry | Provider | Form | Recorded price with its payment basis | Last verified | Link |
|---|---|---|---|---|---|
| EntryTR-1107 | ProviderEnhance MD | FormInjection · device not recorded | Recorded price$322 Published figure · GLP-1 Elite — 12-month selection, advertised $322/mo; billed every 48 weeks Initial payment not verified Recurring price conditions not established Prescription and clinician eligibility required. The visible card states $322/mo and billing every 48 weeks; the total selected invoice, initial collection and renewal amount are not established. No calendar-month or full-term invoice is inferred. Named plan terms and general 28-day subscription wording differ. | Last verifiedOctober 2026 | EnrollPaid link |
| EntryTR-1102 | ProviderOpen Water Rx | FormOral · dosage form not recorded | Recorded price$365 Per month · Combined oral program — 1-month recurring plan Clinician approval and prescription required. Published $365 one-month combined-program charge; the pricing term guide states monthly billing and renewal until canceled. This is not a separate price for either ingredient or a guaranteed individual prescription. | Last verifiedOctober 2026 | Record |